4 Results for "

anti-NASH

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "anti-NASH" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-151932
CAS No.: 3037847-72-3
Purity:  95.94%
Target:  

FXR

Research Areas:  

Inflammation/Immunology

FXR agonist 3 is an anti-NASH agent, acting by activating FXR. FXR agonist 3 inhibits COL1A1, TGF-β1, α-SMA and TIMP1 expression with anti-fibrogenic activity. FXR agonist 3 significantly reduces liver steatosis and inflammation, improves liver fibrosis level .
loading...
    loading...
Cat. No.: HY-172105
CAS No.: 3028778-28-8
Target:  

PPAR

Anti-NASH agent 2 (compound 21) is an inhibitor of de novo adipogenesis activity and α-SMA gene expression. Anti-NASH agent 2 improves hepatic steatosis, edema, inflammatory infiltrates, and liver fibrosis in NASH mouse models .
loading...
    loading...
Cat. No.: HY-155525
CAS No.: 2409685-41-0
Purity:  98.49%
Target:  

PPAR

Anti-NASH agent 1 (compound 3d),a derivative of Elafibranor (HY-16737),is a potent agonist of PPAR-α/δ,targeting to nonalcoholic steatohepatitis (NASH). Anti-NASH agent 1 (3-10 mg/kg; 4 weeks) improves hyperlipidemia,liver fat degeneration and liver inflammation in Methionine-choline deficiency (MCD) induced NASH mice model. Anti-NASH agent 1 shows low liver toxicity and potent liver protection effect .
loading...
    loading...
Cat. No.: HY-149831
CAS No.: 3004676-77-8
Purity:  99.95%
Target:  

FXR

Research Areas:  

Metabolic Disease

ZLY28 is the first-in-class intestinal restricted and orally active FXR and FABP1 dual modulator. ZLY28 also is a novel anti-NASH agent. ZLY28 can be used for the research of nonalcoholic steatohepatitis (NASH) .
loading...
    loading...